Amyris Valuation
Is AMRS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMRS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate AMRS *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate AMRS *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMRS *?
Other financial metrics that can be useful for relative valuation.
What is AMRS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$37.20k |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.9x |
Enterprise Value/EBITDA | -1.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AMRS *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.5x | ||
GPL Graft Polymer (UK) | 0.4x | n/a | UK£174.7k |
PSM Plasma System | 0.2x | n/a | zł878.7k |
XPC XP Chemistries | 5.3x | n/a | kr3.6m |
BUXL Buxly Paints | 0.2x | n/a | PK₨133.7m |
AMRS * Amyris | 0.0001x | 27.4% | Mex$37.2k |
Price-To-Sales vs Peers: AMRS * is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (1.1x).
Price to Earnings Ratio vs Industry
How does AMRS *'s PE Ratio compare vs other companies in the South American Chemicals Industry?
Price-To-Sales vs Industry: AMRS * is good value based on its Price-To-Sales Ratio (0x) compared to the Global Chemicals industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is AMRS *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.0001x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AMRS *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.